Decreased plasma neurotrophin-4/5 levels in bipolar disorder patients in mania

Revista Brasileira de Psiquiatria

Volumn 36, Issue 4, 2014, Pages 340-343

  Barbosa, Izabela G ^a   Morato, Isabela B ^a   Huguet, Rodrigo B ^b   Rocha, Fabio L ^b   Machado Vieira, Rodrigo ^c,d   Teixeira, Antônio L ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Instituto de Previdência Dos Servidores Do Estado de Minas Gerais IPSEMG   (Brazil)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biomarker; Bipolar disorder; Depression; Mania; Neurotrophin

Indexed keywords

ANTICONVULSIVE AGENT; LITHIUM; NEUROLEPTIC AGENT; NEUROTROPHIN 3; NEUROTROPHIN 4; BIOLOGICAL MARKER; NERVE GROWTH FACTOR;

ADULT; AGE; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HAMILTON SCALE; HUMAN; KOLMOGOROV SMIRNOV TEST; MALE; MANIA; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; PSYCHIATRIST; REMISSION; TOBACCO DEPENDENCE; YOUNG MANIA RATING SCALE; BLOOD; CASE CONTROL STUDY; EVALUATION STUDY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; REFERENCE VALUE;

ADULT; BIOLOGICAL MARKERS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; NEUROTROPHIN 3; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; STATISTICS, NONPARAMETRIC;

EID: 84908185807     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/1516-4446-2014-1380     Document Type: Article

References (15)

1. Pfaffenseller B, Fries GR, Wollenhaupt-Aguiar B, Colpo GD, Stertz L, Panizzutti B, et al. Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder. Expert Rev Neurother. 2013;13:827-42.
2. Teixeira AL, Barbosa IG, Diniz BS, Kummer A. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomark Med. 2010;4:871-87.
3. Fernandes BS, Gama CS, Ceresér KM, Yatham LN, Fries GR, Colpo G, et al. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and metaregression analysis. J Psychiatr Res. 2011;45:995-1004.
4. Machado-Vieira R, Dietrich MO, Leke R, Cereser VH, Zanatto V, Kapczinski F, et al. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry. 2007;61:142-4.
5. Barbosa IG, Huguet RB, Neves FS, Reis HJ, Bauer ME, Janka Z, et al. Impaired nerve growth factor homeostasis in patients with bipolar disorder. World J Biol Psychiatry. 2011;12:228-32.
6. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22-33;quiz 34-57.
7. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-96.
8. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry.1978;133:429-35.
9. Walz JC, Magalhães PV, Giglio LM, Cunha AB, Stertz L, Fries GR, et al. Increased serum neurotrophin-4/5 levels in bipolar disorder. J Psychiatr Res. 2009;43:721-3.
10. Otsuki K, Uchida S, Watanuki T, Wakabayashi Y, Fujimoto M, Matsubara T, et al. Altered expression of neurotrophic factors in patients with major depression. J Psychiatr Res. 2008;42:1145-53.
11. Runge EM, Hoshino N, Biehl MJ, Ton S, Rochlin MW. Neurotrophin-4 is more potent than brain-derived neurotrophic factor in promoting, attracting and suppressing geniculate ganglion neurite outgrowth. Dev Neurosci. 2012;34:389-401.
12. Walz JC, Andreazza AC, Frey BN, Cacilhas AA, Ceresér KM, Cunha AB, et al. Serum neurotrophin-3 is increased during manic anddepressive episodes in bipolar disorder. Neurosci Lett. 2007;415:87-9.
13. Fernandes BS, Gama CS, Walz JC, Ceresér KM, Fries GR, Colpo G, et al. Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes. J Psychiatr Res. 2010;44:561-5.
14. Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer- Sant’Anna M, Klamt F, et al. Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res. 2011;45: 156-61.
15. Wu R, Fan J, Zhao J, Calabrese JR, Gao K. The relationship between neurotrophins and bipolar disorder. Expert Rev Neurother. 2014;14:51-65.